Maha Abdallaoui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maha Abdallaoui has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abdelhakim Lakhdar
Research Laboratory of Nervous System Diseases, Neurosensory Disorders & Disability, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco
1 shared publication - Bouchra El Moutawakil
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco
1 shared publication - Hicham El Otmani
Neurology Department, Ibn Rochd University Hospital Center, Casablanca, Morocco
1 shared publication - Mohamed Abdoh Rafai
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Research Laboratory on Nervous System Diseases, Neurosensory Diseases and Disability, Faculty of Medicine and Pharmacy, Casablanca, Morocco
1 shared publication - Mohamed Daghi
Research Laboratory of Nervous System Diseases, Neurosensory Disorders & Disability, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco
1 shared publication - Nadia Tahiri Jouti
Laboratory of Cellular and Molecular Inflammatory, Degenerative and Oncologic Pathophysiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Subthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...
- 1 September 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Open AccessSubthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...